This inventor holds 1 USPTO granted patent. Top assignee: Crispr Therapeutics Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Paul Tetteh: Innovator in Genetic Engineering
Introduction
Paul Tetteh is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of advanced therapeutic techniques. His work focuses on enhancing the functionality of T cells for improved anti-tumor activity.
Latest Patents
Paul Tetteh holds a patent titled "Genetically Engineered T Cells with PTPN2 Knockout Have Improved Functionality and Anti-Tumor Activity." This innovative patent highlights his commitment to advancing cancer treatment through genetic modifications.
Career Highlights
Currently, Paul Tetteh is associated with Crispr Therapeutics AG, where he continues to push the boundaries of genetic research. His expertise in T cell engineering has positioned him as a key player in the biotechnology sector.
Conclusion
Paul Tetteh's contributions to genetic engineering and his innovative patent reflect his dedication to improving cancer therapies. His work at Crispr Therapeutics AG showcases the potential of genetic modifications in medical science.